U.S. Study Confirms Safety of AstraZeneca Covid-19 Vaccine
The coronavirus vaccine developed by AstraZeneca and the University of Oxford is 79% effective in preventing symptomatic illness and 100%
Ugonnabo Ngwu March 22, 2021
- May 21, 2025
The coronavirus vaccine developed by AstraZeneca and the University of Oxford is 79% effective in preventing symptomatic illness and 100%
Several European nations have temporarily halted the rollout of the Oxford-AstraZeneca Covid-19 vaccine over reports of fatal brain hemorrhages and
Ghana is expected to receive additional two million doses of AstraZeneca Covid-19 vaccines by the end of May, News Ghana
Nigeria will get 4 million doses of AstraZeneca vaccine next week in the first tranche of Covax facility consignment to
The move by South Africa to trade the AstraZeneca jab comes as the government tries to tame the fast-spreading variant.
The coronavirus vaccine developed by the University of Oxford and British pharmaceutical giant AstraZeneca provides “100 percent protection” against severe
AstraZeneca Plc and the University of Oxford face mounting criticism about their coronavirus vaccine trial results after it emerged that
In terms of distribution, which is the foremost challenge in getting a vaccine across the world, the AstraZeneca vaccine will
By clicking the Subscribe button, you confirm that you have read our Privacy Policy and consent to receive newsletters from us.
We uphold the highest standards of journalistic integrity and ethical reporting, ensuring that truth and transparency prevail in all our content.
Arbiterz profiles Nigerians creating livelihoods and building businesses and analyses the economic and political ideas that shape the opportunities and constraints they encounter.
brandstories@arbiterz.com
+234-1-4489262 | 1-454 8069
7th Floor, Mulliner Towers, 39, Alfred Rewane Road, Ikoyi, Lagos.
brandstories@arbiterz.com
brandstories@arbiterz.com
© Arbiterz 2025, All Rights Reserved. | Powered by ONMATECH.
Get notified about new articles
